Tanmiah Food Company (TADAWUL:2281)

Verve Therapeutics Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	77.7	88.91	111.03	267.05	185.89	60.46
Cash & Short-Term Investments	77.7	88.91	111.03	267.05	185.89	60.46
Cash Growth	-51.04%	-19.93%	-58.42%	43.66%	207.47%	152.77%
Accounts Receivable	392.5	348.77	257.14	205.5	219.45	448.7
Other Receivables	-	50.63	114.94	14.27	23.12	24.32
Receivables	392.5	399.4	372.08	219.77	242.57	473.02
Inventory	551.74	545.01	406.21	416.95	301.61	221.23
Prepaid Expenses	411.68	38.01	41.14	39.35	29.39	24.01
Other Current Assets	-	257.4	45.65	78.05	73.8	61.21
Total Current Assets	1,434	1,329	976.11	1,021	833.26	839.94
Property, Plant & Equipment	1,585	1,367	947.86	687	490.94	355.03
Long-Term Investments	90.2	88.11	81.64	88.27	0.77	0.77
Other Intangible Assets	9.46	9.1	6.77	4.15	2.67	1.6
Long-Term Deferred Tax Assets	2.5	2.5	-	-	-	-
Total Assets	3,121	2,795	2,012	1,801	1,328	1,197
Accounts Payable	618.86	244.97	199.8	184.29	151.86	161.39
Accrued Expenses	-	309.68	176.94	161.02	119.88	94.28
Short-Term Debt	365.19	386.02	290.97	290.74	285.44	313.44
Current Portion of Long-Term Debt	16.63	16.63	-	33.12	52.94	-
Current Portion of Leases	84.21	88.92	80.32	55.82	63.48	55.13
Current Income Taxes Payable	23.35	19.81	11.34	10.51	8.64	9.91
Current Unearned Revenue	-	0.13	0.64	0.29	0.75	-
Other Current Liabilities	-	11.03	20.72	11.01	11.22	9.07
Total Current Liabilities	1,108	1,077	780.73	746.8	694.21	643.23
Long-Term Debt	574.96	333.68	122.51	40.59	27.38	-
Long-Term Leases	520.71	494.61	330.13	264.32	151.09	124.02
Total Liabilities	2,319	2,017	1,332	1,138	971.44	849.81
Common Stock	200	200	200	200	200	200
Retained Earnings	426.94	408.04	344.85	340.39	156.2	147.54
Comprehensive Income & Other	73.98	73.98	73.98	73.98	-	-
Total Common Equity	700.91	682.02	618.82	614.37	356.2	347.54
Minority Interest	101.01	96.67	61.45	48.24	-	-
Shareholders' Equity	801.92	778.69	680.27	662.61	356.2	347.54
Total Liabilities & Equity	3,121	2,795	2,012	1,801	1,328	1,197
Total Debt	1,562	1,320	823.93	684.59	580.34	492.59
Net Cash (Debt)	-1,484	-1,231	-712.9	-417.54	-394.45	-432.13
Net Cash Per Share	-74.20	-61.55	-35.64	-20.88	-19.72	-21.61
Filing Date Shares Outstanding	20	20	20	20	20	20
Total Common Shares Outstanding	20	20	20	20	20	20
Working Capital	325.38	251.55	195.38	274.36	139.05	196.71
Book Value Per Share	35.05	34.10	30.94	30.72	17.81	17.38
Tangible Book Value	691.46	672.92	612.06	610.22	353.54	345.93
Tangible Book Value Per Share	34.57	33.65	30.60	30.51	17.68	17.30
Land	-	55.22	48.1	46.73	45.64	26.74
Buildings	-	84.98	83.77	68.65	96.75	95.83
Machinery	-	393.28	307.07	251.64	283.67	252.05
Construction In Progress	-	417.9	261.67	130.62	92.55	25.25
Leasehold Improvements	-	108.04	63.26	45.53	26.7	23.33

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.